CEO and Chairman of BioStem Technologies (OTC: BSEM) has been honored as 2025 Florida Entrepreneur of The Year® Winner by Ernst & Young - a prestigious recognition that could propel BSEM to national and global stages while elevating patience care and setting new standards in MedTech excellence.
The future belongs to regenerative medicine, and BioStem Technologies (OTC: BSEM) is emerging as a trailblazer driving innovation, rapid revenue growth, and groundbreaking advancements. This expanding MedTech company utilizes the unique healing properties of perinatal tissue to develop, produce, and bring to market allografts designed for regenerative therapies in advanced wound care.
At the heart of BSEM's approach is its proprietary BioREtain® processing technology, enabling the creation of life-changing products that deliver meaningful patient outcomes. Several positive news announcements are reflecting the tremendous growth potential of BSEM. This includes recently announcing record preliminary net revenue of $72.5 million for Q1 2025. This is a 73% increase compared to $41.9 million in Q1 2024. The company also ended the quarter with cash on hand at $26.7 million, an increase from $22.8 million on December 31st, 2024.
This was the strongest first quarter in the company's history! On the capital markets front, BSEM remains in active review with the SEC regarding its Form 10 registration and uplisting process, and it looks forward to completing this milestone and becoming listed on Nasdaq. Being listed on the NASDAQ would open up the stock to new investors, especially on the institutional front!
Not long ago Jason Matuszewski, CEO and Chairman of the Board of BSEM was named an Entrepreneur Of The Year 2025 Florida Award winner! Winning the Entrepreneur of The Year® Florida Award highlights the company's leadership, showcasing his ability to steer BSEM with vision and purpose.
For investors, this signals that the company is led by a proven, respected entrepreneur who has been independently vetted for driving meaningful growth and innovation-an important indicator of the company's potential for long-term success.
Matuszewski now advances to the national Entrepreneur of The Year® competition this fall, with a chance to represent the U.S. on the global stage in 2026. As he moves forward, the company will benefit from ongoing exposure through Ernst & Young's network, events, and media. Combined with BSEM's existing product pipeline and potential FDA-related milestones. This creates a powerful narrative that may help sustain momentum, both fundamentally and in the stock price. This award is not just an honor-it's a strategic asset that validates BSEM's mission, leadership, and investment case at a critical stage in the company's growth trajectory.
See why Zack's Small Cap Research has issued a $35.50 price target on BSEM shares! |
This message is a paid advertisement for BioStem Technologies Inc. (OTC: BSEM) from Sideways Frequency and Huge Alerts. It's Today Media, LLC. receives a fixed fee for each subscriber that clicks on a link in this email, totaling up to $5,150.00. Other than the compensation received for this advertisement sent to subscribers, It's Today Media and its principals are not affiliated with either Sideways Frequency or Huge Alerts. It's Today Media and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither It's Today Media nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from It's Today Media to buy or sell any security. It's Today Media has not evaluated the accuracy of any claims made in this advertisement. It's Today Media recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding BioStem Technologies Inc. (OTC: BSEM) on Huge Alerts' website for additional information about the relationship between Huge Alerts and BioStem Technologies Inc. (OTC: BSEM). |
|
|
Editor's Note: Above is an important message from one of our highly valued sponsors. Please read it carefully as they have some special information to share with you. |
|
|
It's Today Media LLC, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above.
The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation.
Nothing in this e-mail should be considered personalized financial advice. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.
It's Today Media, LLC, 930 Tahoe Blvd, Ste 802 PMB 458, Incline Village, Nevada 89451, United States
Sent to: [email protected]
Unsubscribe |
|
|
|
